--- title: "GEMAC LG-4 type contact network pole working vehicle officially sets off to assist efficient railway construction" type: "News" locale: "en" url: "https://longbridge.com/en/news/239729882.md" description: "According to GEMAC, on May 9th, the LG-4 type contact network pole working vehicle independently developed by GEMAC has completed its preparation work and has officially been sent to the user site in Sanggendalai. This model is specifically designed for the construction of electrified railway poles and also has crane functions, allowing for efficient completion of various material lifting tasks" datetime: "2025-05-12T00:36:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/239729882.md) - [en](https://longbridge.com/en/news/239729882.md) - [zh-HK](https://longbridge.com/zh-HK/news/239729882.md) --- # GEMAC LG-4 type contact network pole working vehicle officially sets off to assist efficient railway construction According to GEMAC, on May 9th, the LG-4 type contact network pole working vehicle independently developed by GEMAC has completed its preparation work and has officially been sent to the user site in Sanggendalai. This model is specifically designed for the construction of electrified railway poles and also has crane functions, allowing it to efficiently complete various material lifting tasks ### Related Stocks - [301048.CN](https://longbridge.com/en/quote/301048.CN.md) ## Related News & Research - [PetroTal Announces Availability of Annual General Meeting Materials | PTALF Stock News](https://longbridge.com/en/news/287013425.md) - [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md) - [SCORE Act pulled from House floor after CBC opposition](https://longbridge.com/en/news/286925702.md) - [10:27 ETTrilith Foundation Expands Mental Health Resources for Storymakers and Athletes During Mental Health Awareness Month](https://longbridge.com/en/news/286930795.md) - [First healthy volunteers receive TRIV-573 doses in Triveni Bio’s Phase I trial](https://longbridge.com/en/news/286888745.md)